DEUTSCHE BANK AG\ - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 15 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$90,000
-21.1%
72,425
+1.9%
0.00%
Q4 2021$114,000
-72.6%
71,047
-44.4%
0.00%
Q3 2021$416,000
-5.2%
127,749
+83.9%
0.00%
Q2 2021$439,000
+3890.9%
69,454
+1473.5%
0.00%
Q3 2020$11,000
+10.0%
4,414
-31.0%
0.00%
Q4 2019$10,0006,394
+2031.3%
0.00%
Q2 2019$0300
+4185.7%
0.00%
Q3 2018$0
-100.0%
7
-99.7%
0.00%
Q2 2018$4,0002,2070.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 242,237$511,0000.10%
CVI Holdings, LLC 432,305$912,0000.06%
Virtu Financial LLC 271,937$574,0000.04%
XTX Topco Ltd 20,392$43,0000.02%
Newbridge Financial Services Group, Inc. 7,000$15,0000.01%
Renaissance Technologies 3,304,140$6,972,0000.01%
GSA CAPITAL PARTNERS LLP 22,925$48,0000.01%
Bienville Capital Management, LLC 28,379$60,0000.01%
Cutler Group LLC / CA 223,100$116,0000.01%
Royal Fund Management, LLC 15,000$31,0000.01%
View complete list of ATOSSA THERAPEUTICS INC shareholders